cro.directory
← Compare landing

Aldeyra Therapeutics vs Scimega Research

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAldeyra TherapeuticsScimega Research
SummaryBiopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.Canadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors.
Services
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • US FDA Regulatory Strategy
  • Immunology & Inflammation Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Regulatory Affairs
Modalities
  • Small Molecule
Data not yet provided.
Indications
  • Immunology
  • Rare Disease
  • Ophthalmology
  • Oncology
Phases
  • Phase II
  • Phase III
  • Phase I
  • Phase II
  • Phase III
Sourcing modelsData not yet provided.Data not yet provided.
LocationsData not yet provided.
  • Laval, Laval, Québec, Canada
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Aldeyra Therapeutics alternatives · Scimega Research alternatives

Markdown mirror: /compare/aldeyra/scimega.md